Maryam Osooly
Vancouver, BC V6T1Z3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthesis and evaluation of HOPO-O8-Methyl-tetrazine as a bifunctional chelator for use in [89Zr]Zr4+, [161Tb]Tb3+ and [227Th]Th4+ radioimmunoconjugates.
Journal: Journal of inorganic biochemistry
Published: July 02, 2025
Chelating [227Th]Th4+ for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors.
Journal: Bioconjugate chemistry
Published: May 10, 2025
Preclinical evaluation of [225Ac]Ac-crown-TATE - An alpha-emitting radiopharmaceutical for neuroendocrine tumors.
Journal: Nuclear medicine and biology
Published: April 08, 2024
Development of an immunosuppressed orthotopic hepatocellular carcinoma rat model for the evaluation of chemo- and radioembolization therapies.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: October 22, 2023
H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics.
H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics.
Journal: Bioconjugate chemistry
Published: November 15, 2022
H4picoopa─Robust Chelate for 225Ac/111In Theranostics.
Journal: Bioconjugate chemistry
Published: September 20, 2022
[213Bi]Bi3+/[111In]In3+-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation.
Journal: Bioconjugate chemistry
Published: March 03, 2022
Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis.
Journal: Scientific reports
Published: July 18, 2020
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.
Journal: Investigational new drugs
Published: May 12, 2014
Topotecan and doxorubicin combination to treat recurrent ovarian cancer: the influence of drug exposure time and delivery systems to achieve optimum therapeutic activity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 11, 2013
Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
Journal: Journal of pharmaceutical sciences
Published: September 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026